Similar organisations to International Myotonic Dystrophy Organization Inc
-
Alliance/Advocacy Organizations
-
244.
CONGENITAL HYPERINSULINISM INTERNATIONAL
Improving the lives of babies, children, and adults with hyperinsulinism (HI) by supporting HI families, research, and awareness to prevent brain damage & death CHI is dedicated to improving the lives of people living with Congenital Hyperinsulinism.
6467
Glen Ridge
-
Specifically Named Diseases Research
-
245.
Muscular Dystrophy Association
MDA is the #1 voluntary health organization in the United States for people living with #MuscularDystrophy, #ALS, and related #neuromuscular diseases.
162873
Chicago
-
Medical Disciplines
-
246.
Connecticut Osteopathic Medical Society Inc
WildApricot by @Personifycorp helps over 32,000 membership organizations with an all-in-one solution.
15223
Glastonbury
-
Hospitals and Primary Medical Care Facilities
-
247.
Center for Medical Technology Policy
Center for Medical Technology Policy Home of #GPC (Green Park Collaborative), a multi-stakeholder forum developing #CoreOutcomeSets for clinical trial design.
423
Baltimore
Dysautonomia Youth Network of America, Inc.
Thank you for visiting the official facebook page of the DYNA, Inc.
4400
Waldorf
Foundation for Angelman Syndrome Therapeutics
FAST is the premier patient advocacy organization working to cure Angelman syndrome.
AUSTIN
-
Medical Disciplines
-
250.
Washington Association of Naturopathic Physician
The Voice for Naturopathic Medicine since 1934 WANP is a professional membership organization that supports naturopathic physicians who are licensed in Washington State.
1035
Kenmore
-
Fund Raising and/or Fund Distribution
-
251.
Zc4H2 Research Foundation Inc
A parent-led, nonprofit organization created to support scientific and medical research on ZC4H2 Associated Rare Disorders (ZARD).
560
Albany
-
Specifically Named Diseases
-
252.
FOUNDATION FOR PRADER-WILLI
Foundation for Prader-Willi Research focused on treatments & cure for PWS Our Research FPWRs research programs aim to develop new therapies that will improve the health and wellbeing of those with PWS.
2031
COVINA








